<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03650868</url>
  </required_header>
  <id_info>
    <org_study_id>KIA 2018/155</org_study_id>
    <nct_id>NCT03650868</nct_id>
  </id_info>
  <brief_title>The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery</brief_title>
  <official_title>The Effect of Thoracal Paravertebral Block on Seroma Reduction in Breast Surgery, a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kocaeli University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kocaeli University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thoracal paravertebral block (TPVB) is a commonly prefferred regional anesthesia technique to
      provide postoperative analgesia. In addition, the successful use of TPVB is reported for some
      seroma related pain cases. Postoperative analgesia in breast surgery is a difficult and
      overworked issue due to etensive surgery and complex innervation of the breast and in
      addition to this complex mechanisms, seroma accumulation has a negative effect for patients
      postoperatively. With this study, the investigators aimed to study the effect of TPVB on
      seroma reduction for breast cancer surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">February 26, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Seroma quantitiy</measure>
    <time_frame>24 hour postoperatively.</time_frame>
    <description>Seroma quantitiy of all patients will be recorded after 24 hour postoperatively.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Seroma</condition>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention will be applied to control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TPVB group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thoracal paravertebral block will be performed with 20cc of 0,25% bupivacaine preoperatively.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Thoracal paravertebral block</intervention_name>
    <description>Thoracal paravertebral block will be performed before the surgery to the TPVB group.</description>
    <arm_group_label>TPVB group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-70 years of agge

          -  ASA I-II

          -  Undergoing elective breast cancer surgery

        Exclusion Criteria:

          -  obesity (body mass index &gt;35 kg/m2)

          -  infection of the skin at the site of needle puncture area

          -  patients with known allergies to any of the study drugs

          -  coagulopathy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alparslan Kus</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kocaeli Üniversitesi Tıp Fakültesi</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kocaeli University</name>
      <address>
        <city>Kocaeli</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>August 27, 2018</study_first_submitted>
  <study_first_submitted_qc>August 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <last_update_submitted>February 27, 2019</last_update_submitted>
  <last_update_submitted_qc>February 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kocaeli University</investigator_affiliation>
    <investigator_full_name>Alparslan Kus</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Thoracal Paravertebral Block</keyword>
  <keyword>Breast Surgery</keyword>
  <keyword>Seroma Reduction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Seroma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

